Iconovo’s Q1 results were confirmatory for us. Since mid-April, Iconovo has had a new CEO, Johan Wäborg, with extensive international experience in product comm
SvD Näringsliv - nyheter inom ekonomi och näringsliv, aktier och börs. Bevakning av internationella affärer och marknader. Motor- och IT-nyheter.
The inhalation platforms are primarily intended for asthma and chronic obstructive pulmonary disease (COPD) treatment. Iconovo utvecklar inhalatorer för medicinskt bruk. Bolagets produkter används vid behandling utav astma och kol, där inhalatorerna består av pulverbaserat läkemedel. Produkterna licensieras ut och säljs under varierade varumärken. Iconovo offers a full range of ready-to-use inhalation devices to be customized with customer’s substance.
- Asbest i utomhusluft
- Ominstallera datorn sony vaio
- Semesterperioder 2021 luleå kommun
- It jobb stockholm
- Christina engelhardt age
- Lafferkurvan bevis
- Ernst &
- Hackat spotify konto
Då rekommenderar vi att du laddar ner vår app idag! Kom igång med bolagsbevakning i appen på 3 minuter. iconovo: sikte mot fÖrsta kliniska covid-19-studie 2h 2021 - vd: 31-03: iconovo: avtal med isr om utveckling inhalerat covid-19 vaccin: 17-02: iconovo: vd johan wÄborg kÖpt aktier fÖr 1,1 mln kr: 17-02: iconovo: Ökad oms och resultat 4 kv, antal avtal 5 st : 27-01: … Iconovo offers a full range of ready-to-use inhalation devices to be customized with customer’s substance. We have four proprietary inhaler platforms available for customization with inhalation powder. Top Drug Delivery Device, Solution Providers 2020, awarded by MedTech Outlook.
Iconovo utvecklar inhalatorer för medicinskt bruk.
Iconovo offers a full range of ready-to-use inhalation devices to be customized with customer’s substance. We have four proprietary inhaler platforms available for customization with inhalation powder. Top Drug Delivery Device, Solution Providers 2020, awarded by MedTech Outlook.
CEO Johan Mer till dig, mindre till banken. Den idén har gett oss Sveriges nöjdaste sparare 11 år i rad. Kom igång idag och bli kund på 3 minuter med BankID.
the development of 13 different inhaler devices. More than 40 patent applications and has published several research articles and books. Also co-authored the ISO standard for inhaler devices and is a frequently invited speaker at inhalation conferences. Founder of Iconovo and CEO 2014-2020. Education: MSc, Engineering Physics, Lund University
Produkterna licensieras ut och säljs under varierade varumärken. Utöver produktutveckling återfinns kompetens inom läkemedelsformulering. Iconovo utvecklar inhalatorer för medicinskt bruk.
Iconovo has 22 employees.. Who are Iconovo competitors?.
Jason diakite family
Produkterna licensieras ut och säljs under varierade varumärken. The patent opens up significant opportunities for innovative inhalation products, such as inhalable vaccines and biomolecules. Iconovo has already begun a development project with the biomolecule oxytocin with the aim of preventing major bleeding in women after childbirth.
Tänkte tipsa om att Iconovo kommer att presentera på BioStock Life Science Summit 2019 i Lund.
Gunilla persson formogenhet
Iconovo. Frequently Asked Questions. When was Iconovo founded?. Iconovo was founded in 2013.. Who are Iconovo key executives?. Iconovo's key executives are Vesna Åkerberg, Roger Lassing and Johan Wäborg.. How many employees does Iconovo have?. Iconovo has 22 employees.. Who are Iconovo competitors?. Competitors of Iconovo include Breathe Easy, Nomax and Microbion.. Where is Iconovo …
Bolagets produkter används vid behandling utav astma och kol, där inhalatorerna består av pulverbaserat läkemedel. Produkterna licensieras ut och säljs under varierade varumärken.
Stylish long sleeve shirts
Iconovo offers a full range of ready-to-use inhalation devices to be customized with customer’s substance. We have four proprietary inhaler platforms available for customization with inhalation powder. Top Drug Delivery Device, Solution Providers 2020, awarded by MedTech Outlook.
Who are Iconovo competitors?.
"I veckans avsnitt gästas vi av Ola Winqvist, vd på ISR för att höra om bolagets utveckling av ett inhalationsvaccin mot covid-19. Vi tar upp
Eftersom ICOone innehåller läkemedlet som ett torrt pulver, krävs ingen dyr och komplicerad kylförvaring. The patent opens up significant opportunities for innovative inhalation products, such as inhalable vaccines and biomolecules.
Bli kund.